These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18452147)

  • 1. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
    Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
    Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.
    Kawata K; Yang GX; Ando Y; Tanaka H; Zhang W; Kobayashi Y; Tsuneyama K; Leung PS; Lian ZX; Ridgway WM; Ansari AA; He XS; Gershwin ME
    Hepatology; 2013 Sep; 58(3):1094-104. PubMed ID: 23532950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.
    Huang W; Kachapati K; Adams D; Wu Y; Leung PS; Yang GX; Zhang W; Ansari AA; Flavell RA; Gershwin ME; Ridgway WM
    J Autoimmun; 2014 May; 50():123-34. PubMed ID: 24556277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.
    Yoshida K; Yang GX; Zhang W; Tsuda M; Tsuneyama K; Moritoki Y; Ansari AA; Okazaki K; Lian ZX; Coppel RL; Mackay IR; Gershwin ME
    Hepatology; 2009 Nov; 50(5):1494-500. PubMed ID: 19676134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis reveals distinctive protein profiles involved in CD8
    Zhang W; Zhang R; Zhang J; Sun Y; Leung PS; Yang GX; Shuai Z; Ridgway WM; Gershwin ME
    Cell Mol Immunol; 2018 Aug; 15(8):756-767. PubMed ID: 29375127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.
    Ando Y; Yang GX; Kenny TP; Kawata K; Zhang W; Huang W; Leung PS; Lian ZX; Okazaki K; Ansari AA; He XS; Invernizzi P; Ridgway WM; Lu Q; Gershwin ME
    J Autoimmun; 2013 Mar; 41():111-9. PubMed ID: 23395552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
    Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
    Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.
    Oertelt S; Lian ZX; Cheng CM; Chuang YH; Padgett KA; He XS; Ridgway WM; Ansari AA; Coppel RL; Li MO; Flavell RA; Kronenberg M; Mackay IR; Gershwin ME
    J Immunol; 2006 Aug; 177(3):1655-60. PubMed ID: 16849474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.
    Moritoki Y; Zhang W; Tsuneyama K; Yoshida K; Wakabayashi K; Yang GX; Bowlus C; Ridgway WM; Ueno Y; Ansari AA; Coppel RL; Mackay IR; Flavell RA; Gershwin ME; Lian ZX
    Gastroenterology; 2009 Mar; 136(3):1037-47. PubMed ID: 19118554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy.
    Yang JB; Wang YH; Yang W; Lu FT; Ma HD; Zhao ZB; Jia YJ; Tang W; Tsuneyama K; Ridgway WM; Gershwin ME; Lian ZX
    J Autoimmun; 2016 Jan; 66():108-17. PubMed ID: 26432598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.
    Zhang W; Tsuda M; Yang GX; Tsuneyama K; Rong G; Ridgway WM; Ansari AA; Flavell RA; Coppel RL; Lian ZX; Gershwin ME
    Hepatology; 2010 Jul; 52(1):215-22. PubMed ID: 20578264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis.
    Zhang W; Moritoki Y; Tsuneyama K; Yang GX; Ilan Y; Lian ZX; Gershwin ME
    Clin Exp Immunol; 2009 Sep; 157(3):359-64. PubMed ID: 19664143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells.
    Tanaka H; Zhang W; Yang GX; Ando Y; Tomiyama T; Tsuneyama K; Leung P; Coppel RL; Ansari AA; Lian ZX; Ridgway WM; Joh T; Gershwin ME
    Clin Exp Immunol; 2014 Nov; 178(2):253-61. PubMed ID: 25041369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.
    Irie J; Wu Y; Wicker LS; Rainbow D; Nalesnik MA; Hirsch R; Peterson LB; Leung PS; Cheng C; Mackay IR; Gershwin ME; Ridgway WM
    J Exp Med; 2006 May; 203(5):1209-19. PubMed ID: 16636131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of primary biliary cirrhosis: materials and methods.
    Leung PS; Yang GX; Dhirapong A; Tsuneyama K; Ridgway WM; Gershwin ME
    Methods Mol Biol; 2012; 900():291-316. PubMed ID: 22933075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice.
    Tsuda M; Zhang W; Yang GX; Tsuneyama K; Ando Y; Kawata K; Park O; Leung PS; Coppel RL; Ansari AA; Ridgway WM; Gao B; Lian ZX; Flavell R; He XS; Gershwin ME
    Hepatology; 2013 Feb; 57(2):806-16. PubMed ID: 22576253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8
    Ma HD; Ma WT; Liu QZ; Zhao ZB; Liu MZ; Tsuneyama K; Gao JM; Ridgway WM; Ansari AA; Gershwin ME; Fei YY; Lian ZX
    J Autoimmun; 2017 Mar; 78():19-28. PubMed ID: 28129932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous development of an autoimmune hepatitis - primary biliary cholangitis overlap syndrome in dnTGFβRII Aire
    Long J; Yang SY; Huang MX; Luo PY; Li L; Tsuneyama K; Ansari AA; Lu L; Gershwin ME; Lian ZX; Zhao ZB
    J Pathol; 2023 Jun; 260(2):222-234. PubMed ID: 36853094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca.
    De Paiva CS; Volpe EA; Gandhi NB; Zhang X; Zheng X; Pitcher JD; Farley WJ; Stern ME; Niederkorn JY; Li DQ; Flavell RA; Pflugfelder SC
    PLoS One; 2011; 6(12):e29017. PubMed ID: 22194977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4
    Zhao ZB; Lu FT; Ma HD; Wang YH; Yang W; Long J; Miao Q; Zhang W; Tian Z; Ridgway WM; Cao J; Gershwin ME; Lian ZX
    Cell Mol Immunol; 2020 Feb; 17(2):178-189. PubMed ID: 30874628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.